04875nam 2200553Ia 450 991082510110332120200520144314.01-61705-130-6(CKB)2670000000387536(EBL)1218689(OCoLC)851972265(SSID)ssj0000916144(PQKBManifestationID)12402809(PQKBTitleCode)TC0000916144(PQKBWorkID)10874728(PQKB)10962089(MiAaPQ)EBC1218689(EXLCZ)99267000000038753620130220d2013 uy 0engur|n|---uuuuutxtrdacontentcrdamediacrrdacarrierOncology boards flash review /Francis P. Worden, Rami N. Khoriaty, editors ; Binu Malhotra, Brian Parkin, associate editorsNew York Demos Medical Pub.c20131 online resourceIncludes index.1-936287-81-1 Cover; Title; Copyright; Contents; Contributors; Preface; Part I: Hematologic Malignancies; Chapter 1: Acute Myeloid Leukemia; Epidemiology; Etiology and Risk Factors; Classification; Signs and Symptoms; Diagnostic Criteria; Indications for Treatment; Prognostic Factors; Treatment; Acute Lymphoblastic Leukemia (ALL); Hairy Cell Leukemia (HCL); Chapter 2: Chronic Lymphocytic Leukemia; Epidemiology; Etiology and Risk Factors; Staging; Signs and Symptoms; Diagnostic Criteria; Indications for Treatment; Prognostic Factors; Treatment; Special ConsiderationsChapter 3: Chronic Myeloid Leukemia and Myeloproliferative NeoplasmsChronic Myelogenous Leukemia (CML); Myeloproliferative Neoplasms (General); Polycythemia Vera (PV); Essential Thrombocythemia (ET); Primary Myelofibrosis (PMF); Chapter 4: Myelodysplastic Syndromes; Epidemiology; Etiology and Risk Factors; Classification; Signs and Symptoms; Diagnostic Criteria; Prognostic Factors; Indications for Treatment; Treatment; Chapter 5: Hodgkin's Lymphoma; Epidemiology; Etiology and Risk Factors; Staging; Signs and Symptoms; Diagnostic Criteria; Indications for Treatment; Prognostic FactorsTreatmentSpecial Considerations; Chapter 6: Non-Hodgkin's Lymphoma-Low Grade; Epidemiology; Etiology and Risk Factors; Staging; Signs and Symptoms; Follicular Lymphoma; Marginal Zone Lymphoma; Lymphoplasmacytic Lymphoma/Waldenström's Macroglobulinemia; Small Lymphocytic Lymphoma (See Chapter 2); Chapter 7: Non-Hodgkin's Lymphoma-High Grade; Diffuse Large B-Cell Lymphoma (DLBCL); Burkitt's Lymphoma (BL); Mantle Cell Lymphoma (MCL); Lymphomas in HIV/AIDS Patients; Chapter 8: Peripheral T-Cell Lymphomas; Epidemiology; Etiology and Risk Factors; Staging; Signs and Symptoms; Diagnostic CriteriaIndications for TreatmentPrognostic Factors; Treatment; Special Considerations; Chapter 9: Multiple Myeloma and Plasma Cell Dyscrasias; Epidemiology; Etiology and Risk Factors; Staging; Signs and Symptoms; Diagnostic Criteria; Indications for Treatment; Prognostic Factors; Treatment; Special Considerations; Part II: Aerodigestive Malignancies; Chapter 10: Non-Small Cell Lung Cancer; Epidemiology; Etiology and Risk Factors; Screening; Prevention; Pathology; Signs and Symptoms; Diagnostic Workup; Staging; General Treatment Principles; Treatment by Stage; Chapter 11: Small Cell Lung CancerEpidemiologyEtiology and Risk Factors; Staging; Signs and Symptoms; Diagnosis; Prognostic Factors; Treatment; Chapter 12: Malignant Pleural Mesothelioma; Epidemiology; Etiology and Risk Factors; Staging and Histological Classification; Signs and Symptoms; Diagnosis; Prognostic Factors; Treatment; Special Considerations; Chapter 13: Thymoma and Thymic Carcinoma; Epidemiology; Etiology and Risk Factors; Staging and Histological Classification; Signs and Symptoms; Diagnosis; Prognostic and Risk Factors; Treatment; Special ConsiderationsChapter 14: Head and Neck Cancers and Salivary Gland TumorsCoverage extends across the range of major hematologic malignancies and solid tumors, as well as reviews of pharmacology, biostatistics, genetics and tumor biology, and survivorship and palliative care. Each topic is consistently presented with the key points summarized in bullet point form for easy recall. Question-based headings enable the reader to systematically review and assess his knowledge.OncologyExaminationsStudy guidesCancerExaminationsStudy guidesOncologyExaminationsCancerExaminations616.99/40076Worden Francis P1044247MiAaPQMiAaPQMiAaPQBOOK9910825101103321Oncology boards flash review3959478UNINA